← Browse by Condition
Medical Condition

anaplastic lymphoma kinase positive

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06765109 Phase 3
Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Enrollment
450 pts
Location
United States, Argen...
Sponsor
Nuvalent Inc.
View Trial →